课题基金 / 基金详情

Abnormal Activation of Thymocytes High-Mobility Group Box Protein (TOX) in Cutaneous T Cell Lymphomas: Pathogenic Significance and Clinical Applications

Abnormal Activation of Thymocytes High-Mobility Group Box Protein (TOX) in Cutaneous T Cell Lymphomas: Pathogenic Significance and Clinical Applications
皮肤 T 细胞淋巴瘤中胸腺细胞高迁移率族盒蛋白 (TOX) 的异常激活：致病意义和临床应用
批准号：
225786
负责人：
Zhou Youwen
金额：
$24.79万
依托单位：
Vancouver Coastal Health Research Institute
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-03-01 至 2014-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=225786&lang=en
关键词：
Cutaneous T Cell Lymphoma Epigenomics Molecular Disease Markers Sezary Cells Sezary Syndrome T Cell Development Tox

项目摘要

项目成果

Zhou Youwen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cutaneous T cell lymphomas (CTCL) are cancers that are developed from the CD4+ subset of the mature T lymphocytes in the skin. Although rare, these cancers are highly aggressive in advanced stages, causing high mortality because there are no curative ther
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Efficacy and safety of maresin 1 as a repigmentation therapy for vitiligo
  • 批准号：
    467401
  • 项目类别：
    Operating Grants
  • 资助金额：
    $3.64万
  • 财政年份：
    2022
  • 负责人：
    Zhou Youwen
  • 依托单位：
    University of British Columbia
Role of CLEC12B+ macrophages in the pathogenesis of vitiligo and melanoma
Characterising the genetic mutations in familial hyperhidrosis palmaris et plantaris
A diagnostic test for cutaneous T cell lymphomas
  • 批准号：
    256776
  • 项目类别：
    Operating Grants
  • 资助金额：
    $11.05万
  • 财政年份：
    2012
  • 负责人：
    Zhou Youwen
  • 依托单位：
    University of British Columbia
海外基金